Global and United States Cancer Diagnostics Market Report & Forecast 2023-2028

Report ID: 1738382 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Cancer Diagnostics Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Cancer Diagnostics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Cancer Diagnostics Market Size for the Year 2017-2028
        1.2.2 Global Cancer Diagnostics Market Size for the Year 2017-2028
    1.3 Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Cancer Diagnostics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Cancer Diagnostics Market Dynamics
        1.4.1 Cancer Diagnostics Industry Trends
        1.4.2 Cancer Diagnostics Market Drivers
        1.4.3 Cancer Diagnostics Market Challenges
        1.4.4 Cancer Diagnostics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Cancer Diagnostics by Type
    2.1 Cancer Diagnostics Market Segment by Type
        2.1.1 Platform-based
        2.1.2 Instrument-based
    2.2 Global Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Cancer Diagnostics Market Size by Type (2017-2028)
    2.4 United States Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Cancer Diagnostics Market Size by Type (2017-2028)
3 Cancer Diagnostics by Application
    3.1 Cancer Diagnostics Market Segment by Application
        3.1.1 Breast Cancer
        3.1.2 Lung Cancer
        3.1.3 Colorectal Cancer
        3.1.4 Others
    3.2 Global Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Cancer Diagnostics Market Size by Application (2017-2028)
    3.4 United States Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Cancer Diagnostics Market Size by Application (2017-2028)
4 Global Cancer Diagnostics Competitor Landscape by Company
    4.1 Global Cancer Diagnostics Market Size by Company
        4.1.1 Top Global Cancer Diagnostics Companies Ranked by Revenue (2021)
        4.1.2 Global Cancer Diagnostics Revenue by Player (2017-2022)
    4.2 Global Cancer Diagnostics Concentration Ratio (CR)
        4.2.1 Cancer Diagnostics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Cancer Diagnostics in 2021
        4.2.3 Global Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Cancer Diagnostics Headquarters, Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Cancer Diagnostics Headquarters and Area Served
        4.3.2 Global Cancer Diagnostics Companies Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Cancer Diagnostics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Cancer Diagnostics Market Size by Company
        4.5.1 Top Cancer Diagnostics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Cancer Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Cancer Diagnostics Market Size by Region
    5.1 Global Cancer Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Cancer Diagnostics Market Size by Region (2017-2028)
        5.2.1 Global Cancer Diagnostics Market Size by Region: 2017-2022
        5.2.2 Global Cancer Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Cancer Diagnostics Market Size YoY Growth 2017-2028
        6.1.2 North America Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Cancer Diagnostics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Cancer Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Cancer Diagnostics Market Size YoY Growth 2017-2028
        6.3.2 Europe Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Cancer Diagnostics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Cancer Diagnostics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Becton, Dickinson and Company
        7.1.1 Becton, Dickinson and Company Company Details
        7.1.2 Becton, Dickinson and Company Business Overview
        7.1.3 Becton, Dickinson and Company Cancer Diagnostics Introduction
        7.1.4 Becton, Dickinson and Company Revenue in Cancer Diagnostics Business (2017-2022)
        7.1.5 Becton, Dickinson and Company Recent Development
    7.2 GE Healthcare
        7.2.1 GE Healthcare Company Details
        7.2.2 GE Healthcare Business Overview
        7.2.3 GE Healthcare Cancer Diagnostics Introduction
        7.2.4 GE Healthcare Revenue in Cancer Diagnostics Business (2017-2022)
        7.2.5 GE Healthcare Recent Development
    7.3 Abbott
        7.3.1 Abbott Company Details
        7.3.2 Abbott Business Overview
        7.3.3 Abbott Cancer Diagnostics Introduction
        7.3.4 Abbott Revenue in Cancer Diagnostics Business (2017-2022)
        7.3.5 Abbott Recent Development
    7.4 Roche
        7.4.1 Roche Company Details
        7.4.2 Roche Business Overview
        7.4.3 Roche Cancer Diagnostics Introduction
        7.4.4 Roche Revenue in Cancer Diagnostics Business (2017-2022)
        7.4.5 Roche Recent Development
    7.5 Thermo Fisher Scientific
        7.5.1 Thermo Fisher Scientific Company Details
        7.5.2 Thermo Fisher Scientific Business Overview
        7.5.3 Thermo Fisher Scientific Cancer Diagnostics Introduction
        7.5.4 Thermo Fisher Scientific Revenue in Cancer Diagnostics Business (2017-2022)
        7.5.5 Thermo Fisher Scientific Recent Development
    7.6 Agilent Technologies
        7.6.1 Agilent Technologies Company Details
        7.6.2 Agilent Technologies Business Overview
        7.6.3 Agilent Technologies Cancer Diagnostics Introduction
        7.6.4 Agilent Technologies Revenue in Cancer Diagnostics Business (2017-2022)
        7.6.5 Agilent Technologies Recent Development
    7.7 Illumina
        7.7.1 Illumina Company Details
        7.7.2 Illumina Business Overview
        7.7.3 Illumina Cancer Diagnostics Introduction
        7.7.4 Illumina Revenue in Cancer Diagnostics Business (2017-2022)
        7.7.5 Illumina Recent Development
    7.8 Siemens Healthcare
        7.8.1 Siemens Healthcare Company Details
        7.8.2 Siemens Healthcare Business Overview
        7.8.3 Siemens Healthcare Cancer Diagnostics Introduction
        7.8.4 Siemens Healthcare Revenue in Cancer Diagnostics Business (2017-2022)
        7.8.5 Siemens Healthcare Recent Development
    7.9 C.R. Bard
        7.9.1 C.R. Bard Company Details
        7.9.2 C.R. Bard Business Overview
        7.9.3 C.R. Bard Cancer Diagnostics Introduction
        7.9.4 C.R. Bard Revenue in Cancer Diagnostics Business (2017-2022)
        7.9.5 C.R. Bard Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Cancer Diagnostics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Cancer Diagnostics Market Trends
    Table 3. Cancer Diagnostics Market Drivers
    Table 4. Cancer Diagnostics Market Challenges
    Table 5. Cancer Diagnostics Market Restraints
    Table 6. Global Cancer Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cancer Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cancer Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cancer Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cancer Diagnostics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cancer Diagnostics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Cancer Diagnostics Revenue Share by Player, 2017-2022
    Table 13. Global Cancer Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics as of 2021)
    Table 15. Top Players of Cancer Diagnostics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Cancer Diagnostics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Cancer Diagnostics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Cancer Diagnostics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Cancer Diagnostics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Cancer Diagnostics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Cancer Diagnostics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Cancer Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Cancer Diagnostics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Cancer Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Cancer Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Cancer Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Becton, Dickinson and Company Company Details
    Table 31. Becton, Dickinson and Company Business Overview
    Table 32. Becton, Dickinson and Company Cancer Diagnostics Product
    Table 33. Becton, Dickinson and Company Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 34. Becton, Dickinson and Company Recent Development
    Table 35. GE Healthcare Company Details
    Table 36. GE Healthcare Business Overview
    Table 37. GE Healthcare Cancer Diagnostics Product
    Table 38. GE Healthcare Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 39. GE Healthcare Recent Development
    Table 40. Abbott Company Details
    Table 41. Abbott Business Overview
    Table 42. Abbott Cancer Diagnostics Product
    Table 43. Abbott Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 44. Abbott Recent Development
    Table 45. Roche Company Details
    Table 46. Roche Business Overview
    Table 47. Roche Cancer Diagnostics Product
    Table 48. Roche Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 49. Roche Recent Development
    Table 50. Thermo Fisher Scientific Company Details
    Table 51. Thermo Fisher Scientific Business Overview
    Table 52. Thermo Fisher Scientific Cancer Diagnostics Product
    Table 53. Thermo Fisher Scientific Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 54. Thermo Fisher Scientific Recent Development
    Table 55. Agilent Technologies Company Details
    Table 56. Agilent Technologies Business Overview
    Table 57. Agilent Technologies Cancer Diagnostics Product
    Table 58. Agilent Technologies Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 59. Agilent Technologies Recent Development
    Table 60. Illumina Company Details
    Table 61. Illumina Business Overview
    Table 62. Illumina Cancer Diagnostics Product
    Table 63. Illumina Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 64. Illumina Recent Development
    Table 65. Siemens Healthcare Company Details
    Table 66. Siemens Healthcare Business Overview
    Table 67. Siemens Healthcare Cancer Diagnostics Product
    Table 68. Siemens Healthcare Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 69. Siemens Healthcare Recent Development
    Table 70. C.R. Bard Company Details
    Table 71. C.R. Bard Business Overview
    Table 72. C.R. Bard Cancer Diagnostics Product
    Table 73. C.R. Bard Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 74. C.R. Bard Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cancer Diagnostics Product Picture
    Figure 2. Global Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cancer Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Cancer Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Cancer Diagnostics Market Share in Global 2017-2028
    Figure 7. Cancer Diagnostics Report Years Considered
    Figure 8. Product Picture of Platform-based
    Figure 9. Product Picture of Instrument-based
    Figure 10. Global Cancer Diagnostics Market Share by Type in 2022 & 2028
    Figure 11. Global Cancer Diagnostics Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Cancer Diagnostics Market Share by Type (2017-2028)
    Figure 13. United States Cancer Diagnostics Market Share by Type in 2022 & 2028
    Figure 14. United States Cancer Diagnostics Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Cancer Diagnostics Market Share by Type (2017-2028)
    Figure 16. Product Picture of Breast Cancer
    Figure 17. Product Picture of Lung Cancer
    Figure 18. Product Picture of Colorectal Cancer
    Figure 19. Product Picture of Others
    Figure 20. Global Cancer Diagnostics Market Share by Application in 2022 & 2028
    Figure 21. Global Cancer Diagnostics Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Cancer Diagnostics Market Share by Application (2017-2028)
    Figure 23. United States Cancer Diagnostics Market Share by Application in 2022 & 2028
    Figure 24. United States Cancer Diagnostics Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Cancer Diagnostics Market Share by Application (2017-2028)
    Figure 26. North America Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.A.E Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Becton, Dickinson and Company Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
    Figure 55. GE Healthcare Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
    Figure 56. Abbott Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
    Figure 57. Roche Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
    Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
    Figure 59. Agilent Technologies Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
    Figure 60. Illumina Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
    Figure 61. Siemens Healthcare Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
    Figure 62. C.R. Bard Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Becton, Dickinson and Company
GE Healthcare
Abbott
Roche
Thermo Fisher Scientific
Agilent Technologies
Illumina
Siemens Healthcare
C.R. Bard
Frequently Asked Questions
Cancer Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cancer Biomarker

Cancer Biomarker market is segmented by region (country), players, by Type and by Application. Pl ... Read More